Tig Advisors, LLC Sage Therapeutics, Inc. Transaction History
Tig Advisors, LLC
- $1.85 Billion
- Q2 2025
A detailed history of Tig Advisors, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Tig Advisors, LLC holds 83,200 shares of SAGE stock, worth $722,176. This represents 0.04% of its overall portfolio holdings.
Number of Shares
83,200
Previous 2,732,271
96.95%
Holding current value
$722,176
Previous $21.7 Million
96.51%
% of portfolio
0.04%
Previous 1.36%
Shares
2 transactions
Others Institutions Holding SAGE
# of Institutions
222Shares Held
51.1MCall Options Held
759KPut Options Held
440K-
Madison Avenue Partners, LP New York, NY6.08MShares$52.7 Million5.93% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$28.3 Million0.0% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT1.95MShares$16.9 Million0.07% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.92MShares$16.6 Million0.01% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...